AR-V7 Rabbit Monoclonal Antibody Learn More
FEATURED
PRODUCT Anti-EGFR Variant III Rabbit Monoclonal Antibody [RM419]
Validated in IHC, FC, WB, ELISA Learn More
Goat Monoclonal Antibodies Consistent and Reliable Secondaries

Anti-Rabbit lgG Fab Goat Monoclonal Antibody, Clone RMG0l
Anti-Rabbit lgG Fc Goat Monoclonal Antibody, Clone RMG02
Anti-Rabbit igG Goat Monoclonal Antibody, Clone RMG03
Anti-Mouse lgG Fab Goat Monoclonal Antibody, Clone RMG05
Anti-Mouse lgG Fc Goat Monoclonal Antibody, Clone RMG06
Anti-Mouse lgG Goat Monoclonal Antibody, Clone RMG07

Learn More

About Us

RevMAb Biosciences USA, Inc is a biotechnology company focused on the development of recombinant monoclonal antibodies using a revolutionary technology that does not require cell fusion and hybridoma generation. Our mission is to promote personal health by accelerating biomedical research and advancing disease diagnosis. We seek to accomplish this by providing superior monoclonal antibodies to our customers in the research and diagnostic fields.
Details >>

RevMAb FEATURED PRODUCTS

Epitope Tag Anti-His-Tag Rabbit Monoclonal Antibody [RM146X]
Small Molecule Anti-25-OH Vitamin D3 Rabbit Monoclonal Antibody [RM3]
Goat Ab-Mouse IgG Anti-Mouse IgG Fab Goat Monoclonal Antibody [RMG05]
Variant Mutation Anti-EGFRvIII Rabbit Monoclonal Antibody [RM419]
BRAIN tumor markers browse
IMMUNO-ONCOLOGY MARKERS browse

More Products

INQUIRY NOW

Why Choose Us

Our team consists of pioneers in optimizing and transforming rabbit hybridoma technology for commercial application, and developing rabbit monoclonal antibodies for research, diagnostic and therapeutic use. With years of experience and strong expertise in antibody development, RevMAb’s team of scientists aim to revolutionize antibody generation and develop high quality products in order to reveal true science. For more information, please contact us.
About us >>

Publications

References for ARv7 Splice Variant antibody [RM7]

Sowalsky AG et al AR-V7 in Primary Prostate Cancer. MedRxiv. (2022), 10.1101/2022.03.10.22271799. WB, IHC; Human. Read more (AR-V7 in Primary Prostate Cancer) Hu Qet al. Inhibition of CDK9 activity compromises global splicing in prostate cancer cells. RNA BIOLOGY. (2021), 10.1080/15476286.2021.1983287. WB; Human. Read more (PubMed: 34592899) Brady L et al Inter- and intra-tumor heterogeneity o...

References for 6x His-Tag or 10x His-Tag antibody (RM146)

Goto S et al Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models. Cancer Immunol Immunother. (2021), 10.1007/s00262-021-02853-3. FC; Human. Read more (PubMed: 33559069)...

Hit enter to search or ESC to close